{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-004435","form_type":"8-K","ticker":"VRDN","cik":"0001590750","company_name":"Viridian Therapeutics, Inc.\\DE","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.099252+00:00","generated_at":"2026-05-28T04:58:24.259633+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Viridian Therapeutics promotes Seth Harmon to CFO effective Jan 1, 2025","bullets":["Seth Harmon, previously SVP of Finance and Accounting and Principal Financial Officer, appointed CFO effective Jan 1, 2025.","New base salary of $480,000 and target bonus of 40% of base salary.","Received equity awards: stock option with grant date value of $1,662,000 and RSUs with grant date value of $554,000.","Harmon's prior roles include CFO of BioNTech US subsidiary and VP of Finance at Neon Therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-004435","json":"https://secwatch.observer/filing/0001193125-25-004435.json","markdown":"https://secwatch.observer/filing/0001193125-25-004435.md","text":"https://secwatch.observer/filing/0001193125-25-004435.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590750/000119312525004435/0001193125-25-004435-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590750/000119312525004435/d842633d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:58:24.259633+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a2aaec8152","claim":"Seth Harmon was appointed as Chief Financial Officer at Viridian Therapeutics, Inc.\\DE.","evidence_excerpt":"On January 7, 2025, the Board of Directors of Viridian Therapeutics, Inc. (the “Company”) appointed Seth Harmon to serve as the Chief Financial Officer of the Company effective as of January 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590750/000119312525004435/0001193125-25-004435-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}